Overview

Efficacy and Safety of Tolvaptan in the Treatment of Cardiac-Induced Edema in Patients With Heart Failure

Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
A Multicenter, Double-blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tolvaptan in the Treatment of Cardiac-Induced Edema in Patients with Heart Failure
Phase:
Phase 3
Details
Lead Sponsor:
Taiwan Otsuka Pharm. Co., Ltd
Treatments:
Tolvaptan